Showing results (1-10 of 207) with videos related to
Sort By:
Pageof 21
Journal of Clinical Pharmacology|November 17, 2004
Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathyArif Asif, David L Epstein, Murray EpsteinExpert Review of Cardiovascular Therapy|December 19, 2012
Treatment of isolated systolic hypertension in the elderlyDaniel DuprezThe American Journal of Geriatric Cardiology|June 21, 2001
The Growing Role of Calcium Antagonists in Treating Hypertension in the ElderlyMurray EpsteinKidney International Supplements|January 25, 2019
Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arenaMurray EpsteinJournal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Resistant hypertension: prevalence and evolving conceptsMurray EpsteinThe American Journal of Medicine|October 31, 2006
Aldosterone blockade: an emerging strategy for abrogating progressive renal diseaseMurray EpsteinThe Lancet. Diabetes & Endocrinology|October 3, 2015
Reduction of cardiovascular risk in chronic kidney disease by mineralocorticoid receptor antagonismMurray EpsteinAmerican Journal of Nephrology|April 15, 2021
Aldosterone and Mineralocorticoid Receptor Signaling as Determinants of Cardiovascular and Renal Injury: From Hans Selye to the PresentMurray EpsteinJournal of the American Society of Hypertension : JASH|April 16, 2016
The future for renal denervation depends on embracing the lessons learned from our previous studiesMurray EpsteinJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 10, 2003
Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunctionMurray EpsteinPageof 21